ISSN: 0198-6325
Journal Home
Journal Guideline
Medicinal Research Reviews Q1 Unclaimed
Medicinal Research Reviews is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 150. It has a price of 2750 €. It has an SJR impact factor of 2,864 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,864.
Medicinal Research Reviews focuses its scope in these topics and keywords: advances, targeting, receptor, binding, cancer, drug, diversify, discoverynew, discovery, developments, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
2750 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
2,864
SJR Impact factor150
H Index63
Total Docs (Last Year)242
Total Docs (3 years)13778
Total Refs3346
Total Cites (3 years)237
Citable Docs (3 years)12.98
Cites/Doc (2 years)218.7
Ref/DocOther journals with similar parameters
Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Cell Chemical Biology Q1
Emerging Microbes and Infections Q1
Compare this journals
Aims and Scope
Best articles by citations
Carbonic anhydrase inhibitors
Click chemistry reactions in medicinal chemistry: Applications of the 1,3-dipolar cycloaddition between azides and alkynes
Flavonoids: Promising anticancer agents
The art and practice of structure-based drug design: A molecular modeling perspective
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Antioxidant and other biological activities of phenols from olives and olive oil
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Multicomponent domino reactions for the synthesis of biologically active natural products and drugs
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
New developments in the chemistry and biology of the bioactive constituents of tanshen
Combining docking and molecular dynamic simulations in drug design
Anti-cancer properties of anthraquinones from rhubarb
Boronic acid compounds as potential pharmaceutical agents
New insights on the anticancer properties of dietary polyphenols
Drugs that target dynamic microtubules: A new molecular perspective
Recent progress in the development of coumarin derivatives as potent anti-HIV agents
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Bionanotechnology based on silica nanoparticles
The thioredoxin system?From science to clinic
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Comments